Skip to main content
Top
Published in: Translational Stroke Research 5/2016

01-10-2016 | SI: Challenges and Controversies in Translational Stroke Research

Rodent Models of Vascular Cognitive Impairment

Authors: Yi Yang, Shihoko Kimura-Ohba, Jeffrey Thompson, Gary A. Rosenberg

Published in: Translational Stroke Research | Issue 5/2016

Login to get access

Abstract

Vascular cognitive impairment dementia (VCID), which is an increasingly important cause of dementia in the elderly, lacks effective treatments. Many different types of vascular disease are included under the diagnosis of VCID, including large vessel disease with multiple strokes and small vessel disease with lacunar infarcts and white matter disease. Animal models have been developed to study the multiple forms of VCID. Because of its progressive course, small vessel disease (SVD) is thought to be the optimal form of VCID for treatment. One theory is that the pathophysiology involves hypoxic hypoperfusion resulting in injury to the white matter and neuronal death. Bilateral occlusion of the common carotid arteries (BCAO) in a normotensive rat, which reduces cerebral blood flow, induces hypoxia with white matter damage; this model has been used to test drugs to block the injury. Another model is the spontaneously hypertensive/stroke prone rat (SHR/SP). Hypertension leads to small vessel disease resulting in progressive damage to the white matter, cortex, and hippocampus. Bilateral carotid artery stenosis (BCAS) with coils or ameroid constrictors produces a slower development of changes than BCAO, avoiding the acute ischemia. A few studies have been done with the two-clip, two-vessel occlusion renal model for induction of hypertension. There are benefits and drawbacks to each of these models with the model selected depending on the type of vascular damage that is to be studied. This review describes the most commonly used models, and the drugs that have been used to reduce the damage.
Literature
1.
go back to reference Gorelick PB et al. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42:2672–713.CrossRefPubMedPubMedCentral Gorelick PB et al. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42:2672–713.CrossRefPubMedPubMedCentral
2.
go back to reference Snyder HM et al. Vascular contributions to cognitive impairment and dementia including Alzheimer’s disease. Alzheimers Dement. 2015;11:710–7.CrossRefPubMed Snyder HM et al. Vascular contributions to cognitive impairment and dementia including Alzheimer’s disease. Alzheimers Dement. 2015;11:710–7.CrossRefPubMed
3.
go back to reference Corriveau RA et al. The science of vascular contributions to cognitive impairment and dementia (VCID): a framework for advancing research priorities in the cerebrovascular biology of cognitive decline. Cell Mol Neurobiol. 2016;36:281–8.CrossRefPubMed Corriveau RA et al. The science of vascular contributions to cognitive impairment and dementia (VCID): a framework for advancing research priorities in the cerebrovascular biology of cognitive decline. Cell Mol Neurobiol. 2016;36:281–8.CrossRefPubMed
4.
go back to reference Guerrini U et al. New insights into brain damage in stroke-prone rats: a nuclear magnetic imaging study. Stroke. 2002;33:825–30.CrossRefPubMed Guerrini U et al. New insights into brain damage in stroke-prone rats: a nuclear magnetic imaging study. Stroke. 2002;33:825–30.CrossRefPubMed
5.
go back to reference Nishio K et al. A mouse model characterizing features of vascular dementia with hippocampal atrophy. Stroke. 2010;41:1278–84.CrossRefPubMed Nishio K et al. A mouse model characterizing features of vascular dementia with hippocampal atrophy. Stroke. 2010;41:1278–84.CrossRefPubMed
6.
go back to reference Wakita H et al. Protective effect of cyclosporin a on white matter changes in the rat brain after chronic cerebral hypoperfusion. Stroke. 1995;26:1415–22.CrossRefPubMed Wakita H et al. Protective effect of cyclosporin a on white matter changes in the rat brain after chronic cerebral hypoperfusion. Stroke. 1995;26:1415–22.CrossRefPubMed
7.
go back to reference Walker EJ, Rosenberg GA. Divergent role for MMP-2 in myelin breakdown and oligodendrocyte death following transient global ischemia. J Neurosci Res. 2010;88:764–73.PubMedPubMedCentral Walker EJ, Rosenberg GA. Divergent role for MMP-2 in myelin breakdown and oligodendrocyte death following transient global ischemia. J Neurosci Res. 2010;88:764–73.PubMedPubMedCentral
8.
go back to reference De Reuck J et al. Pathogenesis of Binswanger chronic progressive subcortical encephalopathy. Neurology. 1980;30:920–8.CrossRefPubMed De Reuck J et al. Pathogenesis of Binswanger chronic progressive subcortical encephalopathy. Neurology. 1980;30:920–8.CrossRefPubMed
9.
go back to reference Rigsby CS, Pollock DM, Dorrance AM. Spironolactone improves structure and increases tone in the cerebral vasculature of male spontaneously hypertensive stroke-prone rats. Microvasc Res. 2007;73:198–205.CrossRefPubMedPubMedCentral Rigsby CS, Pollock DM, Dorrance AM. Spironolactone improves structure and increases tone in the cerebral vasculature of male spontaneously hypertensive stroke-prone rats. Microvasc Res. 2007;73:198–205.CrossRefPubMedPubMedCentral
10.
go back to reference Weaver J et al. Tissue oxygen is reduced in white matter of spontaneously hypertensive-stroke prone rats: a longitudinal study with electron paramagnetic resonance. J Cereb Blood Flow Metab. 2014;34:890–6.CrossRefPubMedPubMedCentral Weaver J et al. Tissue oxygen is reduced in white matter of spontaneously hypertensive-stroke prone rats: a longitudinal study with electron paramagnetic resonance. J Cereb Blood Flow Metab. 2014;34:890–6.CrossRefPubMedPubMedCentral
11.
go back to reference Derdeyn CP et al. Variability of cerebral blood volume and oxygen extraction: stages of cerebral haemodynamic impairment revisited. Brain. 2002;125:595–607.CrossRefPubMed Derdeyn CP et al. Variability of cerebral blood volume and oxygen extraction: stages of cerebral haemodynamic impairment revisited. Brain. 2002;125:595–607.CrossRefPubMed
12.
go back to reference Semenza GL. Oxygen sensing, hypoxia-inducible factors, and disease pathophysiology. Annu Rev Pathol. 2014;9:47–71.CrossRefPubMed Semenza GL. Oxygen sensing, hypoxia-inducible factors, and disease pathophysiology. Annu Rev Pathol. 2014;9:47–71.CrossRefPubMed
13.
go back to reference Cunningham LA, Wetzel M, Rosenberg GA. Multiple roles for MMPs and TIMPs in cerebral ischemia. Glia. 2005;50:329–39.CrossRefPubMed Cunningham LA, Wetzel M, Rosenberg GA. Multiple roles for MMPs and TIMPs in cerebral ischemia. Glia. 2005;50:329–39.CrossRefPubMed
14.
go back to reference Yang Y et al. Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat. J Cereb Blood Flow Metab. 2007;27:697–709.CrossRefPubMed Yang Y et al. Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat. J Cereb Blood Flow Metab. 2007;27:697–709.CrossRefPubMed
15.
go back to reference Rosenberg GA. Matrix metalloproteinase-mediated neuroinflammation in vascular cognitive impairment of the Binswanger type. Cell Mol Neurobiol. 2016;36:195–202.CrossRefPubMed Rosenberg GA. Matrix metalloproteinase-mediated neuroinflammation in vascular cognitive impairment of the Binswanger type. Cell Mol Neurobiol. 2016;36:195–202.CrossRefPubMed
16.
go back to reference Candelario-Jalil E, Yang Y, Rosenberg GA. Diverse roles of matrix metalloproteinases and tissue inhibitors of metalloproteinases in neuroinflammation and cerebral ischemia. Neuroscience. 2009;158:983–94.CrossRefPubMed Candelario-Jalil E, Yang Y, Rosenberg GA. Diverse roles of matrix metalloproteinases and tissue inhibitors of metalloproteinases in neuroinflammation and cerebral ischemia. Neuroscience. 2009;158:983–94.CrossRefPubMed
17.
go back to reference Chandler S et al. Matrix metalloproteinases degrade myelin basic protein. Neurosci Lett. 1995;201:223–6.CrossRefPubMed Chandler S et al. Matrix metalloproteinases degrade myelin basic protein. Neurosci Lett. 1995;201:223–6.CrossRefPubMed
18.
go back to reference Cammer W et al. Degradation of basic protein in myelin by neutral proteases secreted by stimulated macrophages: a possible mechanism of inflammatory demyelination. Proc Natl Acad Sci U S A. 1978;75:1554–8.CrossRefPubMedPubMedCentral Cammer W et al. Degradation of basic protein in myelin by neutral proteases secreted by stimulated macrophages: a possible mechanism of inflammatory demyelination. Proc Natl Acad Sci U S A. 1978;75:1554–8.CrossRefPubMedPubMedCentral
19.
go back to reference Cova L et al. Vascular and parenchymal lesions along with enhanced neurogenesis characterize the brain of asymptomatic stroke-prone spontaneous hypertensive rats. J Hypertens. 2013;31:1618–28.CrossRefPubMed Cova L et al. Vascular and parenchymal lesions along with enhanced neurogenesis characterize the brain of asymptomatic stroke-prone spontaneous hypertensive rats. J Hypertens. 2013;31:1618–28.CrossRefPubMed
20.
go back to reference Pillai JJ, Mikulis DJ. Cerebrovascular reactivity mapping: an evolving standard for clinical functional imaging. AJNR Am J Neuroradiol. 2015;36:7–13.CrossRefPubMed Pillai JJ, Mikulis DJ. Cerebrovascular reactivity mapping: an evolving standard for clinical functional imaging. AJNR Am J Neuroradiol. 2015;36:7–13.CrossRefPubMed
21.
go back to reference Cai ZY et al. Minocycline attenuates cognitive impairment and restrains oxidative stress in the hippocampus of rats with chronic cerebral hypoperfusion. Neurosci Bull. 2008;24:305–13.CrossRefPubMed Cai ZY et al. Minocycline attenuates cognitive impairment and restrains oxidative stress in the hippocampus of rats with chronic cerebral hypoperfusion. Neurosci Bull. 2008;24:305–13.CrossRefPubMed
22.
go back to reference Newcombe VF et al. Microstructural basis of contusion expansion in traumatic brain injury: insights from diffusion tensor imaging. J Cereb Blood Flow Metab. 2013;33:855–62.CrossRefPubMedPubMedCentral Newcombe VF et al. Microstructural basis of contusion expansion in traumatic brain injury: insights from diffusion tensor imaging. J Cereb Blood Flow Metab. 2013;33:855–62.CrossRefPubMedPubMedCentral
23.
go back to reference Budde MD et al. The contribution of gliosis to diffusion tensor anisotropy and tractography following traumatic brain injury: validation in the rat using Fourier analysis of stained tissue sections. Brain. 2011;134:2248–60.CrossRefPubMedPubMedCentral Budde MD et al. The contribution of gliosis to diffusion tensor anisotropy and tractography following traumatic brain injury: validation in the rat using Fourier analysis of stained tissue sections. Brain. 2011;134:2248–60.CrossRefPubMedPubMedCentral
25.
go back to reference Schneider JA et al. Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology. 2007;69:2197–204.CrossRefPubMed Schneider JA et al. Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology. 2007;69:2197–204.CrossRefPubMed
26.
27.
go back to reference Schreiber S et al. The pathologic cascade of cerebrovascular lesions in SHRSP: is erythrocyte accumulation an early phase? J Cereb Blood Flow Metab. 2012;32:278–90.CrossRefPubMed Schreiber S et al. The pathologic cascade of cerebrovascular lesions in SHRSP: is erythrocyte accumulation an early phase? J Cereb Blood Flow Metab. 2012;32:278–90.CrossRefPubMed
29.
go back to reference Okamoto Y et al. Cerebral hypoperfusion accelerates cerebral amyloid angiopathy and promotes cortical microinfarcts. Acta Neuropathol. 2012;123:381–94.CrossRefPubMed Okamoto Y et al. Cerebral hypoperfusion accelerates cerebral amyloid angiopathy and promotes cortical microinfarcts. Acta Neuropathol. 2012;123:381–94.CrossRefPubMed
30.
31.
go back to reference Shibata M et al. Selective impairment of working memory in a mouse model of chronic cerebral hypoperfusion. Stroke. 2007;38:2826–32.CrossRefPubMed Shibata M et al. Selective impairment of working memory in a mouse model of chronic cerebral hypoperfusion. Stroke. 2007;38:2826–32.CrossRefPubMed
32.
go back to reference Wakita H et al. Glial activation and white matter changes in the rat brain induced by chronic cerebral hypoperfusion: an immunohistochemical study. Acta Neuropathol (Berl). 1994;87:484–92.CrossRef Wakita H et al. Glial activation and white matter changes in the rat brain induced by chronic cerebral hypoperfusion: an immunohistochemical study. Acta Neuropathol (Berl). 1994;87:484–92.CrossRef
33.
go back to reference Yamada M et al. The influence of chronic cerebral hypoperfusion on cognitive function and amyloid beta metabolism in APP overexpressing mice. PLoS One. 2011;6, e16567.CrossRefPubMedPubMedCentral Yamada M et al. The influence of chronic cerebral hypoperfusion on cognitive function and amyloid beta metabolism in APP overexpressing mice. PLoS One. 2011;6, e16567.CrossRefPubMedPubMedCentral
34.
go back to reference Farkas E, Luiten PG, Bari F. Permanent, bilateral common carotid artery occlusion in the rat: a model for chronic cerebral hypoperfusion-related neurodegenerative diseases. Brain Res Rev. 2007;54:162–80.CrossRefPubMed Farkas E, Luiten PG, Bari F. Permanent, bilateral common carotid artery occlusion in the rat: a model for chronic cerebral hypoperfusion-related neurodegenerative diseases. Brain Res Rev. 2007;54:162–80.CrossRefPubMed
35.
go back to reference Kitamura A et al. Selective white matter abnormalities in a novel rat model of vascular dementia. Neurobiol Aging. 2012;33(1012):e25–35.PubMed Kitamura A et al. Selective white matter abnormalities in a novel rat model of vascular dementia. Neurobiol Aging. 2012;33(1012):e25–35.PubMed
36.
go back to reference Schmidt-Kastner R et al. Astrocytes react to oligemia in the forebrain induced by chronic bilateral common carotid artery occlusion in rats. Brain Res. 2005;1052:28–39.CrossRefPubMed Schmidt-Kastner R et al. Astrocytes react to oligemia in the forebrain induced by chronic bilateral common carotid artery occlusion in rats. Brain Res. 2005;1052:28–39.CrossRefPubMed
37.
go back to reference Ueno M et al. Blood–brain barrier disruption in white matter lesions in a rat model of chronic cerebral hypoperfusion. J Cereb Blood Flow Metab. 2002;22:97–104.CrossRefPubMed Ueno M et al. Blood–brain barrier disruption in white matter lesions in a rat model of chronic cerebral hypoperfusion. J Cereb Blood Flow Metab. 2002;22:97–104.CrossRefPubMed
38.
go back to reference Nakaji K et al. Matrix metalloproteinase-2 plays a critical role in the pathogenesis of white matter lesions after chronic cerebral hypoperfusion in rodents. Stroke. 2006;37:2816–23.CrossRefPubMed Nakaji K et al. Matrix metalloproteinase-2 plays a critical role in the pathogenesis of white matter lesions after chronic cerebral hypoperfusion in rodents. Stroke. 2006;37:2816–23.CrossRefPubMed
39.
go back to reference Ihara M et al. Chronic cerebral hypoperfusion induces MMP-2 but not MMP-9 expression in the microglia and vascular endothelium of white matter. J Cereb Blood Flow Metab. 2001;21:828–34.CrossRefPubMed Ihara M et al. Chronic cerebral hypoperfusion induces MMP-2 but not MMP-9 expression in the microglia and vascular endothelium of white matter. J Cereb Blood Flow Metab. 2001;21:828–34.CrossRefPubMed
40.
go back to reference Sood R et al. Increased apparent diffusion coefficients on MRI linked with matrix metalloproteinases and edema in white matter after bilateral carotid artery occlusion in rats. J Cereb Blood Flow Metab. 2009;29:308–16.CrossRefPubMed Sood R et al. Increased apparent diffusion coefficients on MRI linked with matrix metalloproteinases and edema in white matter after bilateral carotid artery occlusion in rats. J Cereb Blood Flow Metab. 2009;29:308–16.CrossRefPubMed
42.
go back to reference de la Torre JC. Is Alzheimer’s disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics. Lancet Neurol. 2004;3:184–90.CrossRefPubMed de la Torre JC. Is Alzheimer’s disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics. Lancet Neurol. 2004;3:184–90.CrossRefPubMed
43.
go back to reference Ohtani K et al. Blocking the glycine-binding site of NMDA receptors prevents the progression of ischemic pathology induced by bilateral carotid artery occlusion in spontaneously hypertensive rats. Brain Res. 2000;871:311–8.CrossRefPubMed Ohtani K et al. Blocking the glycine-binding site of NMDA receptors prevents the progression of ischemic pathology induced by bilateral carotid artery occlusion in spontaneously hypertensive rats. Brain Res. 2000;871:311–8.CrossRefPubMed
44.
go back to reference Magnoni S et al. Differential alterations in the expression and activity of matrix metalloproteinases 2 and 9 after transient cerebral ischemia in mice. Neurobiol Dis. 2004;17:188–97.CrossRefPubMed Magnoni S et al. Differential alterations in the expression and activity of matrix metalloproteinases 2 and 9 after transient cerebral ischemia in mice. Neurobiol Dis. 2004;17:188–97.CrossRefPubMed
45.
go back to reference Shibata M et al. White matter lesions and glial activation in a novel mouse model of chronic cerebral hypoperfusion. Stroke. 2004;35:2598–603.CrossRefPubMed Shibata M et al. White matter lesions and glial activation in a novel mouse model of chronic cerebral hypoperfusion. Stroke. 2004;35:2598–603.CrossRefPubMed
46.
go back to reference Hattori Y et al. A novel mouse model of subcortical infarcts with dementia. J Neurosci. 2015;35:3915–28.CrossRefPubMed Hattori Y et al. A novel mouse model of subcortical infarcts with dementia. J Neurosci. 2015;35:3915–28.CrossRefPubMed
48.
go back to reference Yamori Y. Overview: studies on spontaneous hypertension-development from animal models toward man. Clin Exp Hypertens A. 1991;13:631–44.PubMed Yamori Y. Overview: studies on spontaneous hypertension-development from animal models toward man. Clin Exp Hypertens A. 1991;13:631–44.PubMed
49.
go back to reference Yamori Y et al. Pathogenetic similarity of strokes in stroke-prone spontaneously hypertensive rats and humans. Stroke. 1976;7:46–53.CrossRefPubMed Yamori Y et al. Pathogenetic similarity of strokes in stroke-prone spontaneously hypertensive rats and humans. Stroke. 1976;7:46–53.CrossRefPubMed
50.
51.
go back to reference Ballerio R et al. Gender differences in endothelial function and inflammatory markers along the occurrence of pathological events in stroke-prone rats. Exp Mol Pathol. 2007;82:33–41.CrossRefPubMed Ballerio R et al. Gender differences in endothelial function and inflammatory markers along the occurrence of pathological events in stroke-prone rats. Exp Mol Pathol. 2007;82:33–41.CrossRefPubMed
52.
go back to reference Rosenberg GA et al. Consensus statement for diagnosis of subcortical small vessel disease. J Cereb Blood Flow Metab. 2016;36:6–25.PubMed Rosenberg GA et al. Consensus statement for diagnosis of subcortical small vessel disease. J Cereb Blood Flow Metab. 2016;36:6–25.PubMed
53.
go back to reference Sironi L et al. Analysis of pathological events at the onset of brain damage in stroke-prone rats: a proteomics and magnetic resonance imaging approach. J Neurosci Res. 2004;78:115–22.CrossRefPubMed Sironi L et al. Analysis of pathological events at the onset of brain damage in stroke-prone rats: a proteomics and magnetic resonance imaging approach. J Neurosci Res. 2004;78:115–22.CrossRefPubMed
54.
go back to reference Lan LF et al. Peroxisome proliferator-activated receptor-gamma agonist pioglitazone ameliorates white matter lesion and cognitive impairment in hypertensive rats. CNS Neurosci Ther. 2015;21:410–6. Lan LF et al. Peroxisome proliferator-activated receptor-gamma agonist pioglitazone ameliorates white matter lesion and cognitive impairment in hypertensive rats. CNS Neurosci Ther. 2015;21:410–6.
55.
go back to reference Tayebati SK et al. Neuroprotective effect of treatment with galantamine and choline alphoscerate on brain microanatomy in spontaneously hypertensive rats. J Neurol Sci. 2009;283:187–94. Tayebati SK et al. Neuroprotective effect of treatment with galantamine and choline alphoscerate on brain microanatomy in spontaneously hypertensive rats. J Neurol Sci. 2009;283:187–94.
56.
go back to reference Amenta F, Tomassoni D. Treatment with nicardipine protects brain in an animal model of hypertension-induced damage. Clin Exp Hypertens. 2004;26:351–61. Amenta F, Tomassoni D. Treatment with nicardipine protects brain in an animal model of hypertension-induced damage. Clin Exp Hypertens. 2004;26:351–61.
57.
go back to reference Jalal FY et al. Hypoxia-induced neuroinflammatory white-matter injury reduced by minocycline in SHR/SP. J Cereb Blood Flow Metab. 2015;35:1145–53. Jalal FY et al. Hypoxia-induced neuroinflammatory white-matter injury reduced by minocycline in SHR/SP. J Cereb Blood Flow Metab. 2015;35:1145–53.
58.
go back to reference Kondo Y et al. Preventive effects of bifemelane hydrochloride on decreased levels of muscarinic acetylcholine receptor and its mRNA in a rat model of chronic cerebral hypoperfusion. Neurosci Res. 1996;24:409–14. Kondo Y et al. Preventive effects of bifemelane hydrochloride on decreased levels of muscarinic acetylcholine receptor and its mRNA in a rat model of chronic cerebral hypoperfusion. Neurosci Res. 1996;24:409–14.
59.
go back to reference Kwon KJ et al. Effects of donepezil, an acetylcholinesterase inhibitor, on neurogenesis in a rat model of vascular dementia. J Neurol Sci. 2014;347:66–77. Kwon KJ et al. Effects of donepezil, an acetylcholinesterase inhibitor, on neurogenesis in a rat model of vascular dementia. J Neurol Sci. 2014;347:66–77.
60.
go back to reference Stasiak K et al. A pilot double blind randomized placebo controlled trial of a prototype computer-based cognitive behavioural therapy program for adolescents with symptoms of depression. Behav Cogn Psychother. 2014;42:385–401. Stasiak K et al. A pilot double blind randomized placebo controlled trial of a prototype computer-based cognitive behavioural therapy program for adolescents with symptoms of depression. Behav Cogn Psychother. 2014;42:385–401.
61.
go back to reference Ozkul A et al. Effects of lithium and lamotrigine on oxidative-nitrosative stress and spatial learning deficit after global cerebral ischemia. Neurochem Res. 2014;39:853–61. Ozkul A et al. Effects of lithium and lamotrigine on oxidative-nitrosative stress and spatial learning deficit after global cerebral ischemia. Neurochem Res. 2014;39:853–61.
62.
go back to reference Dong YF et al. Attenuation of brain damage and cognitive impairment by direct renin inhibition in mice with chronic cerebral hypoperfusion. Hypertension. 2011;58:635–42. Dong YF et al. Attenuation of brain damage and cognitive impairment by direct renin inhibition in mice with chronic cerebral hypoperfusion. Hypertension. 2011;58:635–42.
63.
go back to reference Farkas E et al. Diazoxide and dimethyl sulphoxide prevent cerebral hypoperfusion-related learning dysfunction and brain damage after carotid artery occlusion. Brain Res. 2004;1008:252–60. Farkas E et al. Diazoxide and dimethyl sulphoxide prevent cerebral hypoperfusion-related learning dysfunction and brain damage after carotid artery occlusion. Brain Res. 2004;1008:252–60.
64.
go back to reference Gupta S, Sharma B. Pharmacological modulation of I(1)-imidazoline and alpha2-adrenoceptors in sub acute brain ischemia induced vascular dementia. Eur J Pharmacol. 2014;723:80–90. Gupta S, Sharma B. Pharmacological modulation of I(1)-imidazoline and alpha2-adrenoceptors in sub acute brain ischemia induced vascular dementia. Eur J Pharmacol. 2014;723:80–90.
65.
go back to reference Kim JS et al. Ramipril protects from free radical induced white matter damage in chronic hypoperfusion in the rat. J Clin Neurosci. 2008;15:174–8. Kim JS et al. Ramipril protects from free radical induced white matter damage in chronic hypoperfusion in the rat. J Clin Neurosci. 2008;15:174–8.
66.
go back to reference Xie W et al. Angiotensin-(1-7) improves cognitive function in rats with chronic cerebral hypoperfusion. Brain Res. 2014;1573:44–53. Xie W et al. Angiotensin-(1-7) improves cognitive function in rats with chronic cerebral hypoperfusion. Brain Res. 2014;1573:44–53.
67.
go back to reference Yamada K et al. Effect of a centrally active angiotensin converting enzyme inhibitor, perindopril, on cognitive performance in chronic cerebral hypo-perfusion rats. Brain Res. 2011;1421:110–20. Yamada K et al. Effect of a centrally active angiotensin converting enzyme inhibitor, perindopril, on cognitive performance in chronic cerebral hypo-perfusion rats. Brain Res. 2011;1421:110–20.
68.
go back to reference Takizawa S, Fukuyama N, Hirabayashi H, Kohara S, Kazahari S, Shinohara Y et al. Quercetin, a natural flavonoid, attenuates vacuolar formation in the optic tract in rat chronic cerebral hypoperfusion model. Brain Res. 2003;980:156–60. Takizawa S, Fukuyama N, Hirabayashi H, Kohara S, Kazahari S, Shinohara Y et al. Quercetin, a natural flavonoid, attenuates vacuolar formation in the optic tract in rat chronic cerebral hypoperfusion model. Brain Res. 2003;980:156–60.
69.
go back to reference Li H, Wang J, Wang P, Rao Y, Chen L. Resveratrol reverses the synaptic plasticity deficits in a chronic cerebral hypoperfusion rat model. J Stroke Cerebrovasc Dis. 2016;25:122–28. Li H, Wang J, Wang P, Rao Y, Chen L. Resveratrol reverses the synaptic plasticity deficits in a chronic cerebral hypoperfusion rat model. J Stroke Cerebrovasc Dis. 2016;25:122–28.
70.
go back to reference Wakita H, Ruetzler C, Illoh KO, Chen Y, Takanohashi A, Spatz M et al. Mucosal tolerization to E-selectin protects against memory dysfunction and white matter damage in a vascular cognitive impairment model. J Cereb Blood Flow Metab. 2008;28:341–53. Wakita H, Ruetzler C, Illoh KO, Chen Y, Takanohashi A, Spatz M et al. Mucosal tolerization to E-selectin protects against memory dysfunction and white matter damage in a vascular cognitive impairment model. J Cereb Blood Flow Metab. 2008;28:341–53.
71.
go back to reference Cho KO, La HO, Cho YJ, Sung KW, Kim SY. Minocycline attenuates white matter damage in a rat model of chronic cerebral hypoperfusion. J Neurosci Res. 2006;83:285–91. Cho KO, La HO, Cho YJ, Sung KW, Kim SY. Minocycline attenuates white matter damage in a rat model of chronic cerebral hypoperfusion. J Neurosci Res. 2006;83:285–91.
72.
go back to reference Liu C, Wu J, Gu J, Xiong Z, Wang F, Wang J et al. Baicalein improves cognitive deficits induced by chronic cerebral hypoperfusion in rats. Pharmacol Biochem Behav. 2007;86:423–30. Liu C, Wu J, Gu J, Xiong Z, Wang F, Wang J et al. Baicalein improves cognitive deficits induced by chronic cerebral hypoperfusion in rats. Pharmacol Biochem Behav. 2007;86:423–30.
73.
go back to reference Nakaji K, Ihara M, Takahashi C, Itohara S, Noda M, Takahashi R et al. Matrix metalloproteinase-2 plays a critical role in the pathogenesis of white matter lesions after chronic cerebral hypoperfusion in rodents. Stroke. 2006;37:2816–23. Nakaji K, Ihara M, Takahashi C, Itohara S, Noda M, Takahashi R et al. Matrix metalloproteinase-2 plays a critical role in the pathogenesis of white matter lesions after chronic cerebral hypoperfusion in rodents. Stroke. 2006;37:2816–23.
74.
go back to reference Yang S, Zhou G, Liu H, Zhang B, Li J, Cui R et al. Protective effects of p38 MAPK inhibitor SB202190 against hippocampal apoptosis and spatial learning and memory deficits in a rat model of vascular dementia. BioMed Res Int. 2013;2013:215798. Yang S, Zhou G, Liu H, Zhang B, Li J, Cui R et al. Protective effects of p38 MAPK inhibitor SB202190 against hippocampal apoptosis and spatial learning and memory deficits in a rat model of vascular dementia. BioMed Res Int. 2013;2013:215798.
75.
go back to reference Choi BR et al. Characterization of white matter injury in a rat model of chronic cerebral hypoperfusion. Stroke. 2016;47:542–7. Choi BR et al. Characterization of white matter injury in a rat model of chronic cerebral hypoperfusion. Stroke. 2016;47:542–7.
76.
go back to reference Wakita H, Tomimoto H, Akiguchi I, Lin JX, Ihara M, Ohtani R et al. Ibudilast, a phosphodiesterase inhibitor, protects against white matter damage under chronic cerebral hypoperfusion in the rat. Brain Res. 2003;992:53–9. Wakita H, Tomimoto H, Akiguchi I, Lin JX, Ihara M, Ohtani R et al. Ibudilast, a phosphodiesterase inhibitor, protects against white matter damage under chronic cerebral hypoperfusion in the rat. Brain Res. 2003;992:53–9.
77.
go back to reference Tanaka K, Hori K, Wada-Tanaka N, Nomura M, Ogawa N. FK506 ameliorates the discrimination learning impairment due to preventing the rarefaction of white matter induced by chronic cerebral hypoperfusion in rats. Brain Res. 2001;906:184–9. Tanaka K, Hori K, Wada-Tanaka N, Nomura M, Ogawa N. FK506 ameliorates the discrimination learning impairment due to preventing the rarefaction of white matter induced by chronic cerebral hypoperfusion in rats. Brain Res. 2001;906:184–9.
78.
go back to reference Ueno Y et al. L-carnitine enhances axonal plasticity and improves white-matter lesions after chronic hypoperfusion in rat brain. J Cereb Blood Flow Metab. 2015;35:382–91. Ueno Y et al. L-carnitine enhances axonal plasticity and improves white-matter lesions after chronic hypoperfusion in rat brain. J Cereb Blood Flow Metab. 2015;35:382–91.
79.
go back to reference Pedder H et al. Systematic review and meta-analysis of interventions tested in animal models of lacunar stroke. Stroke. 2014;45:563–70.CrossRefPubMed Pedder H et al. Systematic review and meta-analysis of interventions tested in animal models of lacunar stroke. Stroke. 2014;45:563–70.CrossRefPubMed
Metadata
Title
Rodent Models of Vascular Cognitive Impairment
Authors
Yi Yang
Shihoko Kimura-Ohba
Jeffrey Thompson
Gary A. Rosenberg
Publication date
01-10-2016
Publisher
Springer US
Published in
Translational Stroke Research / Issue 5/2016
Print ISSN: 1868-4483
Electronic ISSN: 1868-601X
DOI
https://doi.org/10.1007/s12975-016-0486-2

Other articles of this Issue 5/2016

Translational Stroke Research 5/2016 Go to the issue

SI: Challenges and Controversies in Translational Stroke Research

Stem Cell Therapy and Administration Routes After Stroke

SI: Challenges and Controversies in Translational Stroke Research

How to Measure Recovery? Revisiting Concepts and Methods for Stroke Studies